- |||||||||| Hepatoren (ifetroban) / Cumberland
Trial completion, Trial primary completion date: Safety and Pharmacokinetics of Ifetroban in Hepatorenal Syndrome Patients (clinicaltrials.gov) - Dec 5, 2015 P2, N=55, Completed, N=24 --> 36 | Trial primary completion date: Dec 2015 --> Jun 2016 Recruiting --> Completed | Trial primary completion date: Dec 2015 --> Jun 2015
- |||||||||| ceftriaxone / Generic mfg., moxifloxacin intravenous / Generic mfg.
Trial completion, Enrollment change, Trial primary completion date: Moxifloxacin Versus Ceftriaxone in the Treatment of Primary Pyogenic Liver Abscess (clinicaltrials.gov) - Dec 5, 2015 P4, N=24, Completed, Active, not recruiting --> Completed | Trial primary completion date: Jun 2014 --> Sep 2012 Recruiting --> Completed | N=48 --> 24 | Trial primary completion date: Apr 2012 --> Dec 2010
- |||||||||| Engerix-B (hepatitis B vaccine recombinant) / GSK
Trial primary completion date: Hepatitis B Booster Study in Adolescence (clinicaltrials.gov) - Dec 4, 2015 P=N/A, N=360, Active, not recruiting, Recruiting --> Completed | N=20 --> 5 | Trial primary completion date: Aug 2016 --> Oct 2015 Trial primary completion date: Aug 2015 --> Nov 2015
- |||||||||| Peyona (caffeine citrate) / Chiesi
Trial initiation date, Trial primary completion date: NOCTUA: Inhibition of VAP-1 by Caffeine in Healthy Human Volunteers Study (clinicaltrials.gov) - Dec 4, 2015 P1, N=63, Not yet recruiting, Enrolling by invitation --> Active, not recruiting Initiation date: Jul 2015 --> Mar 2016 | Trial primary completion date: Sep 2015 --> Sep 2016
- |||||||||| sorafenib / Generic mfg.
Enrollment closed, Trial primary completion date, Metastases: Ph 1 Trial of ADI PEG 20 Plus Sorafenib to Treat Patients With Liver Cancer (clinicaltrials.gov) - Nov 19, 2015 P1, N=21, Active, not recruiting, N=180 --> 0 | Not yet recruiting --> Withdrawn Recruiting --> Active, not recruiting | Trial primary completion date: May 2016 --> Feb 2016
|